This Article supports Sustainable Development Goal 3 by advancing our understanding of the possible role of active immunotherapy against amyloid-β in individuals with mild Alzheimer's disease; the findings of this phase 2a study support the continued clinical development of UB-311 as an active immunotherapy for Alzheimer's disease.

This Article supports Sustainable Development Goal 3 by estimating the incidence and risk factors for vascular cognitive symptoms among first-ever stroke survivors in China, and shows an association of post-stroke cognitive impairment with age, education, and region (western China had higher rates of post-stroke cognitive impairment relative to other regions).

This article contributes to the debate around the use of participatory approaches by giving a tool (cameras) to the most marginalized to revitalize traditional foods (mostly nonmarket and even noncultivated) as a response to food insecurity and possibly malnutrition.

This study analyzed the clinical characteristics of patients with HEV-induced hemolytic anemia, finding a strong association with G6PD deficiency. Vaccinating individuals with G6PD deficiency is crucial to reduce the risk of this condition, aligning with the goal of ensuring good health and well-being for patients with hepatitis

This paper supports SDG 3 by investigating changes in the clinical care cascade of chronic hepatitis B in Beijing; the results indicate that further efforts are needed to scale up testing, linkage to care, and treatment of chronic hepatitis B not only in Beijing but across China, to achieve the goal of elimination hepatitis B virus by 2030.

This Article supports SDG 3 by estimating the disease burden and establishing a baseline of linkage to care for hepatitis B virus in Ho Chi Minh City, Vietnam, showing the feasibility of a large-scale comprehensive screening and access-to-care program for hepatitis B virus elimination in a low-to middle-income country.

This Article supports SDG 3 by describing the association between low economic status and increased prevalence of hepatis B in China and calls for targeted interventions that could reduce this prevalence among poorer populations.

This Article supports SDG 3 by estimating the prevalence of hepatitis B, C and D viruses in Vietnam since 1990; findings indicate that hepatitis B virus is by far the biggest contributor to hepatitis-related morbidity and mortality in Vietnam and so and elimination efforts must focus on screening and treatment of pregnant women and improved provision of active and passive immunisation at birth to prevent vertical transmission.

This Article supports SDG 3 by describing a causal association between HBV infection and extrahepatic cancers in individuals of East Asian ancestry, suggesting this may have implications for cancer screening in patients with chronic HBV infection.

This Article supports SDG 3 by assessing the safety, tolerability, pharmacokinetics, and anti-fibrotic effects of PRI-724 in patients with cirrhosis due to hepatitis B virus and hepatitis B virus, for which there is currently no anti-fibrotic drug therapy available; PRI-724 was well tolerated but further evaluation of its anti-fibrotic effects is warranted.